Limitations of current treatments for systemic lupus erythematosus: a patient and physician survey
Authors:
- 1 July 2013
- journal article
- Published by SAGE Publications in Lupus
- Vol. 22 (8) , 819-826
Abstract
An independent cross-sectional survey assessed systemic lupus erythematosus (SLE) disease and treatment burden. Variables included medication classes prescribed, disease activity, flare occurrences, treatment satisfaction, and validated measures of health-related quality of life (HRQoL), fatigue and work productivity. Of 886 eligible patients (mean age 41.3 years, 89% female), 515 completed the survey. One-third reported moderate-to-severe disease activity, and 31% had flared in the last 12 months. Higher severity of disease activity (moderate-to-severe) was associated with ≥2 medication classes prescribed and treatment regimens that included corticosteroids (CS) (both p < 0.0001). Patients receiving CS reported lower EQ-5D scores ( p = 0.0019) and higher fatigue levels ( p < 0.001), and both patients ( p = 0.0019) and physicians ( p = 0.0001) were less likely to report satisfaction with treatment regimens including CS. Among responders eligible for work ( n = 456), severity of disease activity (moderate-to-severe vs. mild) was associated with unemployment (52.9% vs. 40.8%; p = 0.0189), greater impairment in work productivity (36% vs. 21%; p = 0.0003) and participation in daily activities (41% vs. 21%; p < 0.0001). This survey confirms that SLE and current treatment options substantially impair patients' health status and work productivity. Physician- and patient-reported satisfaction with current treatment regimens, despite poorly controlled disease activity, indicate they are resigned to the limitations of available SLE treatment regimens.Keywords
This publication has 26 references indexed in Scilit:
- Understanding the Epidemiology and Progression of Systemic Lupus ErythematosusSeminars in Arthritis and Rheumatism, 2010
- EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with Rheumatoid Arthritis, Noninflammatory Rheumatic Disorders, and FibromyalgiaThe Journal of Rheumatology, 2009
- Classical test theory and item response theory/Rasch model to assess differences between patient-reported fatigue using 7-day and 4-week recall periodsJournal of Clinical Epidemiology, 2009
- Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understandCurrent Medical Research and Opinion, 2008
- Measurement of fatigue in systemic lupus erythematosus: A systematic reviewArthritis Care & Research, 2007
- Adherence with advice and prescriptions in SLE is mostly good, but better follow up is needed: A study with a questionnaireLupus, 2007
- The systemic lupus erythematosus Tri‐Nation study: Cumulative indirect costsArthritis Care & Research, 2007
- Work dynamics among persons with systemic lupus erythematosusArthritis Care & Research, 2007
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990